The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Clinical and Translational Medicine
(Jul 2023)
SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association
Han Sun Kim,
Doyeon Kim,
Jiwoo Kim,
Sunghyouk Park,
Arvie Camille V. de Guzman
Affiliations
Han Sun Kim
Natural Products Research InstituteCollege of Pharmacy, Seoul National UniversitySeoulSouth Korea
Doyeon Kim
Natural Products Research InstituteCollege of Pharmacy, Seoul National UniversitySeoulSouth Korea
Jiwoo Kim
Natural Products Research InstituteCollege of Pharmacy, Seoul National UniversitySeoulSouth Korea
Sunghyouk Park
Natural Products Research InstituteCollege of Pharmacy, Seoul National UniversitySeoulSouth Korea
Arvie Camille V. de Guzman
Natural Products Research InstituteCollege of Pharmacy, Seoul National UniversitySeoulSouth Korea
DOI
https://doi.org/10.1002/ctm2.1311
Journal volume & issue
Vol. 13, no. 7
pp. n/a – n/a
Abstract
Read online
No abstracts available.
WeChat QR code
Close